UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.
Latest posts by Toimitus (see all)
Persistent uncertainty around US trade policy has kept Canadian businesses on tenterhooks, discouraging hiring. Lue …